Press Releases
October 13, 2009
Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for its Automated Glucose Monitor
Carlsbad, CA October 13, 2009 - Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous’ automated blood glucose monitor. Luminous is developing its monitor to enable clinicians to control hyperglycemia in critical care patients around the world.
March 1, 2008.
Luminous Medical, Inc. announced today that it has completed a $23.5 million round of Series B financing. Adams Street Partners led the investment, joined by new investors RiverVest Venture Partners, and Finistere Ventures. Existing investors De Novo Ventures and Latterell Venture Partners also participated in the round.
November 16,2005
Luminous Medical Secures $9 Million to Commercialize an Automated Glucose Monitor for Critical Care
CARLSBAD, CA, / ALBUQUERQUE, NM, November 16, 2005/ Luminous Medical Inc. announced today the closing of its series A preferred stock financing. The company is commercializing an automated, continuous whole blood glucose monitor for in-hospital use with critically ill patients.